3 Questions: Phillip Sharp on the discoveries that enabled mRNA vaccines for Covid-19
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Sensor can detect scarred or fatty liver tissue
Diagnosing liver damage earlier could help to prevent liver failure in many patients.
Faculty seed projects grow into pandemic research opportunities
MISTI Global Seed Funds are open for proposals after Covid pivot.
Imaging method reveals a “symphony of cellular activities”
Fluorescent imaging technique simultaneously captures different signal types from multiple locations in a live cell.
Small molecule, big potential for treating prostate cancer
MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.
Angelika Amon, cell biologist who pioneered research on chromosome imbalance, dies at 53
Professor and mentor for more than 20 years at MIT redefined scientists’ understanding of the biology of cell division and proliferation.
“The Age of Living Machines” honored by the American Institute of Physics
Author Susan Hockfield, MIT president emerita and professor of neuroscience, receives 2020 Science Communication Award.
Truncated immune system receptors may regulate cellular activity
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
Tyler Jacks, founding director of MIT’s Koch Institute, to step down
A search committee chaired by Institute Professor Phillip Sharp will work to identify a new director for MIT’s pioneering cancer research center.
Technique recovers lost single-cell RNA-sequencing information
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
Three from MIT receive National Health Institute Awards
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
Nanoparticles can turn off genes in bone marrow cells
Using these new particles, researchers could develop treatments for heart disease and other conditions.
Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
3 Questions: Nancy Hopkins on improving gender equality in academia
Molecular biologist and professor emerita advocates for more inclusive science and advises how to get there.